Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis
出版年份 2021 全文链接
标题
Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis
作者
关键词
-
出版物
Scientific Reports
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-10-21
DOI
10.1038/s41598-021-99008-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Modeling dysbiosis of human NASH in mice: Loss of gut microbiome diversity and overgrowth of Erysipelotrichales
- (2021) James K. Carter et al. PLoS One
- Selonsertib for Patients with Bridging Fibrosis or Compensated Cirrhosis Due to NASH: Results from Randomized Ph III STELLAR Trials
- (2020) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- Women have Lower Risk of Nonalcoholic Fatty Liver Disease but Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis
- (2020) Maya Balakrishnan et al. Clinical Gastroenterology and Hepatology
- Why do so many NASH trials fail?
- (2020) Vlad Ratziu et al. GASTROENTEROLOGY
- Hepatic molecular signatures highlight the sexual dimorphism of Non‐Alcoholic SteatoHepatitis (NASH)
- (2020) Jimmy Vandel et al. HEPATOLOGY
- Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0
- (2020) Nathalie Percie du Sert et al. PLOS BIOLOGY
- Sex Differences in NAFLD : State of the Art and Identification of Research Gaps
- (2019) Amedeo Lonardo et al. HEPATOLOGY
- A Bioreactor Technology for Modeling Fibrosis in Human and Rodent Precision‐Cut Liver Slices
- (2019) Hannah L. Paish et al. HEPATOLOGY
- Trends in clinical success rates and therapeutic focus
- (2019) Helen Dowden et al. NATURE REVIEWS DRUG DISCOVERY
- pcaExplorer: an R/Bioconductor package for interacting with RNA-seq principal components
- (2019) Federico Marini et al. BMC BIOINFORMATICS
- AKR1C1‑3, notably AKR1C3, are distinct biomarkers for liver cancer diagnosis and prognosis: Database mining in malignancies
- (2019) Shou‑Feng Zhao et al. Oncology Letters
- Distinct molecular etiologies of male and female hepatocellular carcinoma
- (2019) Heini M. Natri et al. BMC CANCER
- Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
- (2019) Alan Talevi et al. Expert Opinion on Drug Discovery
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer
- (2018) Takuma Tsuchida et al. JOURNAL OF HEPATOLOGY
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Impact of a five-dimensional framework on R&D productivity at AstraZeneca
- (2018) Paul Morgan et al. NATURE REVIEWS DRUG DISCOVERY
- eXpression2Kinases (X2K) Web: linking expression signatures to upstream cell signaling networks
- (2018) Daniel J B Clarke et al. NUCLEIC ACIDS RESEARCH
- Burden of Illness and Economic Model for Patients with Non-Alcoholic Steatohepatitis (NASH) in the United States
- (2018) Zobair M. Younossi et al. HEPATOLOGY
- Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
- (2018) Zobair Younossi et al. HEPATOLOGY
- CXCL6-EGFR-induced Kupffer cells secrete TGF-β1 promoting hepatic stellate cell activation via the SMAD2/BRD4/C-MYC/EZH2 pathway in liver fibrosis
- (2018) Xiaobo Cai et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
- (2018) Fasiha Kanwal et al. GASTROENTEROLOGY
- Temporal Trends Associated With the Rise in Alcoholic Liver Disease-related Liver Transplantation in the United States
- (2018) George Cholankeril et al. TRANSPLANTATION
- Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases
- (2017) Benjamin Wooden et al. GASTROENTEROLOGY
- Nextflow enables reproducible computational workflows
- (2017) Paolo Di Tommaso et al. NATURE BIOTECHNOLOGY
- Mechanisms of hepatic stellate cell activation
- (2017) Takuma Tsuchida et al. Nature Reviews Gastroenterology & Hepatology
- Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/β-catenin-induced FGF18 expression in hepatocellular carcinoma
- (2017) Pengyi Guo et al. ONCOGENE
- Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells
- (2017) Daniel F. Hicks et al. Scientific Reports
- Predicting the Reliability of Drug-target Interaction Predictions with Maximum Coverage of Target Space
- (2017) Antonio Peón et al. Scientific Reports
- Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd
- (2016) Zichen Wang et al. Nature Communications
- FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
- (2016) Len Verbeke et al. Scientific Reports
- Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results
- (2016) Thomas J. Hwang et al. JAMA Internal Medicine
- Smad7 regulates compensatory hepatocyte proliferation in damaged mouse liver and positively relates to better clinical outcome in human hepatocellular carcinoma
- (2015) Teng Feng et al. CLINICAL SCIENCE
- A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection
- (2015) David Y Zhang et al. GUT
- Dose-dependent effects of lesogaberan on reflux measures in patients with refractory gastroesophageal reflux disease: a randomized, placebo-controlled study
- (2014) Philip B Miner et al. BMC GASTROENTEROLOGY
- Inverse correlation of ribosomal protein S27A and multifunctional protein YB-1 in hepatocellular carcinoma
- (2014) Vinoth Prasanna Gunasekaran et al. CLINICAL BIOCHEMISTRY
- A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors
- (2013) N. S. Jahchan et al. Cancer Discovery
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Antifibrotic Activity of Sorafenib in Experimental Hepatic Fibrosis: Refinement of Inhibitory Targets, Dosing, and Window of Efficacy In Vivo
- (2012) Feng Hong et al. DIGESTIVE DISEASES AND SCIENCES
- Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis
- (2012) Luciano Adorini et al. DRUG DISCOVERY TODAY
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
- (2012) Guangchuang Yu et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial
- (2011) G. E. Boeckxstaens et al. GUT
- Upregulation of Hemoglobin Expression by Oxidative Stress in Hepatocytes and Its Implication in Nonalcoholic Steatohepatitis
- (2011) Wensheng Liu et al. PLoS One
- Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease
- (2011) J. T. Dudley et al. Science Translational Medicine
- Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data
- (2011) M. Sirota et al. Science Translational Medicine
- The novel, peripherally restricted GABAB receptor agonist lesogaberan (AZD3355) inhibits acid reflux and reduces esophageal acid exposure as measured with 24-h pHmetry in dogs
- (2010) Lena Brändén et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effects of Lesogaberan on Reflux and Lower Esophageal Sphincter Function in Patients With Gastroesophageal Reflux Disease
- (2010) Guy E. Boeckxstaens et al. GASTROENTEROLOGY
- The GABAB Receptor Inhibits Activation of Hepatic Stellate Cells
- (2009) Fan Xiao et al. DIGESTIVE DISEASES AND SCIENCES
- Identifying Apoptosis-Evasion Proteins/Pathways in Human Hepatoma Cells via Induction of Cellular Hormesis by UV Irradiation
- (2009) Sen-Yung Hsieh et al. JOURNAL OF PROTEOME RESEARCH
- GABAB receptors as drug targets to treat gastroesophageal reflux disease
- (2009) Anders Lehmann PHARMACOLOGY & THERAPEUTICS
- Hepatic stellate cell lipid droplets: A specialized lipid droplet for retinoid storage
- (2008) William S. Blaner et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Synthesis and Pharmacological Evaluation of Novel γ-Aminobutyric Acid Type B (GABAB) Receptor Agonists as Gastroesophageal Reflux Inhibitors
- (2008) Christer Alstermark et al. JOURNAL OF MEDICINAL CHEMISTRY
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
- (2008) Yujin Hoshida et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search